His answer, in short, is that they can be something close to a miracle for the right person, and that they are nowhere near ready to be dropped in the drinking water
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B, ESC National Cardiac Societies, ESC Scientific Document Group
Neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease show preliminary preclinical evidence of BPC-157 benefits
In addition, these medications may target the appetite centers in the brain, further helping to decrease cravings and the urge to overeat